MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Heatmap
  • Русский
  • 中文
  • Español
  • Português
  • 日本語
  • Deutsch
  • 한국어
  • Français
  • Italiano
  • Türkçe
Mineralys Therapeutics, Inc. Common Stock

MLYS

#4211
Mineralys Therapeutics, Inc. - Common Stock
0.3 2 USD
-99.00%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
0.32
0.32
Year Range
0.32
47.65
Daily Change
-99.00%
Monthly Change
-98.78%
6 month change
-99.27%
Year Change
-99.22%
Previous Close
31.5 4
Open
0.3 2
Low
0.3 2
High
0.3 2
Volume
95
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. MLYS
Open full chart Full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 25.99 M
  • Employee 76
  • Founded 2019
  • CEO N/A
  • Website mineralystx.com
  • Headquarter Delaware, United States
  • FIGI BBG00ZXN1GN3
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents

News

Seeking Alpha Seeking Alpha
MLYS
2026.05.12
Mineralys Therapeutics, Inc. (MLYS) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Investing Investing
MLYS
2026.03.13
Jefferies cuts Mineralys Therapeutics price target on drug concerns
Seeking Alpha Seeking Alpha
MLYS AZN
2026.03.13
Mineralys: Big Pharma Threatens To Undermine Likely Hypertension Drug Approval (MLYS)
Investing Investing
MLYS
2026.03.13
Stifel reiterates Buy rating on Mineralys stock, $52 target
Investing Investing
MLYS
2026.03.13
BofA raises Mineralys Therapeutics stock price target on NDA progress
Seeking Alpha Seeking Alpha
MLYS
2026.03.12
Mineralys Therapeutics, Inc. (MLYS) Q4 2025 Earnings Call Transcript
Investing Investing
MLYS
2026.03.12
Mineralys earnings in focus as FDA lorundrostat decision looms
Zacks Zacks
ANIP REPL PHAT MLYS
2026.03.11
Mineralys Stock Rises as FDA Accepts NDA for Hypertension Drug
Investing Investing
MLYS
2026.03.10
Stifel reiterates Mineralys Therapeutics stock rating on lorundrostat data
Investing Investing
MLYS
2026.03.10
H.C. Wainwright reiterates Mineralys stock rating on FDA acceptance
Investing Investing
MLYS
2026.02.18
Rodman sells Mineralys Therapeutics (MLYS) stock for $11,505
Investing Investing
MLYS
2026.02.14
Mineralys Therapeutics MLYS officer sells $569k in stock

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Store
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
Scan to install from App Store Scan to install from Google Play Scan to install from Huawei AppGallery Scan to install APK
MQL5 Channels
Scan to install from App Store Scan to install from Google Play Scan to install from Huawei AppGallery Scan to install APK
Economic Calendar
Scan to install from App Store Scan to install from Google Play Scan to install from Huawei AppGallery Scan to install APK
Risk Disclosure Terms of Use Help Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd